10 Recruiting Cervical Cancer Phase 2 Clinical Trials
Active phase 2 studies for cervical cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Cervical Cancer studiesPhase 2 Studies for Cervical Cancer
🔵 Active, Not Recruiting Phase2
Dostarlimab and Cobolimab in Advanced Cervical Cancer
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔ 🟢 Recruiting Phase2
Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
📍 National Institute of Cancer — Mexico City, Mexico City
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
📍 Smilow Cancer Hospital at Yale New Haven — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase2
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study
📍 BC Cancer - Kelowna — Kelowna, British Columbia
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
📍 Community Cancer Institute — Clovis, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
📍 Virtua Health — Voorhees Township, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase2
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔